Electromed, Inc.
- Jurisdiction
United States - ISIN
US2854091087 (ELMD )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€13.74 ∞% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€54.91M - Gross margin
78.1% - EBIT
€8.29M - EBIT margin
15.1% - Net income
€6.47M - Net margin
11.8%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: May 7, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |